This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Piramal Enterprises Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Narender Rao Somisetti: Innovator in Pharmaceutical Chemistry
Introduction
Narender Rao Somisetti is a notable inventor based in Telangana State, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work has led to advancements in the purity and efficacy of important pharmaceutical compounds.
Latest Patents
Somisetti holds a patent for a process for the preparation of Verapamil hydrochloride. This patent describes a method for synthesizing 5-(3,4-dimethoxyphenylethyl) methyl-amino-2-(3,4-dimethoxyphenyl)-2-isopropyl valeronitrile, commonly known as Verapamil. The process focuses on improving the purity of Verapamil and its hydrochloride form by efficiently removing impurities, resulting in a product with a purity greater than 99%.
Career Highlights
Narender Rao Somisetti is currently associated with Piramal Enterprises Limited, a leading global pharmaceutical company. His role involves research and development in drug formulation and synthesis, contributing to the company's innovative projects in the pharmaceutical sector.
Collaborations
Somisetti has collaborated with several professionals in his field, including Dhileep Kumar Krishnamurthy and Milind Moreshwar Gharpure. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.
Conclusion
Narender Rao Somisetti's contributions to pharmaceutical chemistry, particularly through his patent on Verapamil hydrochloride, highlight his role as an innovator in the industry. His work continues to impact the field positively, ensuring the development of high-purity pharmaceutical products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
